-
1
-
-
84860708876
-
Probiotics for the prevention and treatment of antibiotic-associated diarrhea
-
Hempel S, Newberry S, Maher A, et al. probiotics for the prevention and treatment of antibiotic-associated diarrhea. JAMA. 2012;307:1959-1969.
-
(2012)
JAMA
, vol.307
, pp. 1959-1969
-
-
Hempel, S.1
Newberry, S.2
Maher, A.3
-
2
-
-
55449090398
-
Antibiotic-associated diarrhea: Epidemiology, trends and treatment
-
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008;3:563-578.
-
(2008)
Future Microbiol
, vol.3
, pp. 563-578
-
-
McFarland, L.V.1
-
3
-
-
27544511378
-
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
-
Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037-1042.
-
(2005)
CMAJ
, vol.173
, pp. 1037-1042
-
-
Pepin, J.1
Valiquette, L.2
Cossette, B.3
-
4
-
-
84868017013
-
Burden of gastrointestinal disease in the United States: 2012 Update
-
Perry A, Dellon E, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 Update. Gastroenterology. 2012;143:1179-1187.
-
(2012)
Gastroenterology
, vol.143
, pp. 1179-1187
-
-
Perry, A.1
Dellon, E.2
Lund, J.3
-
5
-
-
57749091990
-
Review of current literature on the economic burden of Clostridium difficile Infection
-
Dubberke E, and Wertheimer A. review of current literature on the economic burden of Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2009;30:57-66.
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 57-66
-
-
Dubberke, E.1
Wertheimer, A.2
-
6
-
-
33645455337
-
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
-
McFarland L. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812-822.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 812-822
-
-
McFarland, L.1
-
7
-
-
77951026738
-
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America
-
Cohen S, Gerding D, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 2010;31:431-455.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 431-455
-
-
Cohen, S.1
Gerding, D.2
Johnson, S.3
-
9
-
-
80054098741
-
Recommendations for probiotic use - 2011 update
-
Floch M, Walker A, Madsne K, et al. Recommendations for probiotic use - 2011 update. J Clin Gastroenterol. 2011;45(suppl):S168-S171.
-
(2011)
J Clin Gastroenterol
, vol.45
, Issue.SUPPL.
-
-
Floch, M.1
Walker, A.2
Madsne, K.3
-
10
-
-
84871349683
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea: A systematic review and meta-analysis
-
Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157:878-888.
-
(2012)
Ann Intern Med
, vol.157
, pp. 878-888
-
-
Johnston, B.C.1
Ma, S.S.2
Goldenberg, J.Z.3
-
11
-
-
0037196211
-
Deficiencies in microbiological quality and labelling of probiotic supplements [1]
-
DOI 10.1016/S0168-1605(01)00703-6, PII S0168160501007036
-
Hamilton-Miller J, Shah S. Deficiencies in microbiological quality and labeling of probiotic supplements. Int J Food Microbiol. 2002;72:175-176. (Pubitemid 34041539)
-
(2002)
International Journal of Food Microbiology
, vol.72
, Issue.1-2
, pp. 175-176
-
-
Hamilton-Miller, J.M.T.1
Shah, S.2
|